1.
Improved benchmark-multiplier method to estimate the prevalence of ever-injecting drug use in Belgium, 2000–10
2.
3.
4.
An 8 year nationwide prospective registration of non-consented HIV testing in Belgium
Estimates of the HIV undiagnosed population in Belgium reveals higher prevalence for MSM with foreign nationality and for geographic areas hosting big cities
5.
6.
7.
8.
9.
Factors influencing the PCDD/F levels in plasma of Belgian blood donors
DIOXIN BODY BURDEN AMONG BLOOD DONORS BEFORE AND AFTER THE BELGIAN DIOXIN/PCB INCIDENT
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants
Application of the CALUX bioassay for epidemiological study: analyses of Belgian human plasma
Good continuum of HIV care in Belgium despite weaknesses in retention and linkage to care among migrants.
Factors associated with the continuum of care of HIV-infectedpatients in Belgium
Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020